Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

89Zr as a PET Surrogate Radioisotope for Scouting Biodistribution of the Therapeutic Radiometals 90Y and 177Lu in Tumor-Bearing Nude Mice After Coupling to the Internalizing Antibody Cetuximab

Lars R. Perk, Gerard W.M. Visser, Maria J.W.D. Vosjan, Marijke Stigter-van Walsum, Bernard M. Tijink, C. René Leemans and Guus A.M.S. van Dongen
Journal of Nuclear Medicine November 2005, 46 (11) 1898-1906;
Lars R. Perk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerard W.M. Visser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria J.W.D. Vosjan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marijke Stigter-van Walsum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard M. Tijink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. René Leemans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guus A.M.S. van Dongen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 46 no. 11 1898-1906
PubMed 
16269605

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2005.

Copyright & Usage 
THE JOURNAL OF NUCLEAR MEDICINE

Author Information

  1. Lars R. Perk, MSc1,
  2. Gerard W.M. Visser, PhD2,
  3. Maria J.W.D. Vosjan, BSc1,
  4. Marijke Stigter-van Walsum, BSc1,
  5. Bernard M. Tijink, MD1,
  6. C. René Leemans, MD, PhD1 and
  7. Guus A.M.S. van Dongen, PhD1
  1. 1Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands
  2. 2Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, The Netherlands
View Full Text

Statistics from Altmetric.com

Cited By...

  • 190 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2005 to April 2025

AbstractFullPdf
Nov 2005647778
Dec 2005204631
Jan 2006191823
Feb 2006133328
Mar 200682325
Apr 200651216
May 200692031
Jun 200692416
Jul 2006859
Aug 2006101212
Sep 200681219
Oct 200671415
Nov 200661423
Dec 200651117
Jan 200772221
Feb 200763222
Mar 200722732
Apr 2007102012
May 200752725
Jun 200772117
Jul 2007122721
Aug 200763116
Sep 200762117
Oct 2007103324
Nov 200763019
Dec 200722017
Jan 200842018
Feb 200833016
Mar 200873320
Apr 200832016
May 200852725
Jun 2008132329
Jul 2008142117
Aug 2008121812
Sep 2008151733
Oct 2008202624
Nov 2008132321
Dec 200881614
Jan 200971212
Feb 200932516
Mar 2009203530
Apr 200992320
May 200972317
Jun 200993321
Jul 200984119
Aug 2009123112
Sep 200943217
Oct 2009193417
Nov 2009252126
Dec 200982517
Jan 2010113121
Feb 201041411
Mar 201051917
Apr 201072422
May 2010103021
Jun 2010121814
Jul 201052018
Aug 2010261618
Sep 2010161418
Oct 20101089
Nov 2010151823
Dec 201062320
Jan 2011102921
Feb 2011112915
Mar 2011101820
Apr 201152118
May 2011132518
Jun 20112417140
Jul 2011182220
Aug 2011271613
Sep 2011281613
Oct 2011352425
Nov 2011382132
Dec 2011271522
Jan 2012261212
Feb 2012412332
Mar 2012281717
Apr 2012352322
May 2012212220
Jun 2012312026
Jul 2012292246
Aug 2012191723
Sep 2012362324
Oct 2012311720
Nov 2012242218
Dec 2012292417
Jan 2013353324
Feb 2013231715
Mar 2013222725
Apr 2013251528
May 2013302419
Jun 2013171923
Jul 2013161416
Aug 201325715
Sep 2013181120
Oct 2013271626
Nov 2013201928
Dec 2013202067
Jan 2014312544
Feb 2014232741
Mar 2014221523
Apr 2014181237
May 2014222024
Jun 2014231642
Jul 2014241133
Aug 20141082431
Sep 2014292135
Oct 2014343248
Nov 2014313743
Dec 2014512838
Jan 2015181123
Feb 2015181235
Mar 2015271637
Apr 201518933
May 2015341422
Jun 201591953
Jul 2015192866
Aug 2015211524
Sep 2015151229
Oct 2015101114
Nov 2015281717
Dec 2015341131
Jan 2016191312
Feb 201624815
Mar 201611913
Apr 20162286
May 201627913
Jun 2016151212
Jul 201615915
Aug 20164710
Sep 201651018
Oct 20168511
Nov 2016162017
Dec 201672018
Jan 2017142013
Feb 2017172116
Mar 2017201517
Apr 20179812
May 20174119
Jun 201741811
Jul 2017171114
Aug 201772212
Sep 201791710
Oct 2017212114
Nov 2017131617
Dec 2017141410
Jan 201861312
Feb 201810169
Mar 20187811
Apr 201813612
May 2018151816
Jun 201841112
Jul 20180129
Aug 2018365
Sep 20181059
Oct 2018161111
Nov 2018171616
Dec 2018493
Jan 20198129
Feb 201981112
Mar 20191446
Apr 201971517
May 201915119
Jun 2019466
Jul 2019101511
Aug 20191155
Sep 201913910
Oct 2019101611
Nov 201919127
Dec 2019398
Jan 20205106
Feb 2020835
Mar 2020141410
Apr 2020131517
May 2020555
Jun 202022111
Jul 2020626
Aug 2020537
Sep 2020765
Oct 202061013
Nov 202091516
Dec 2020121319
Jan 202182320
Feb 2021164020
Mar 2021132110
Apr 202171819
May 2021112910
Jun 202172212
Jul 202181311
Aug 202161613
Sep 20219198
Oct 202192216
Nov 202162020
Dec 202192411
Jan 202251710
Feb 202251111
Mar 20226165
Apr 20226137
May 202234923
Jun 20228466
Jul 202232313
Aug 20227297
Sep 20225148
Oct 202210183
Nov 20227119
Dec 202212104
Jan 2023205112
Feb 202332510
Mar 2023171810
Apr 20238166
May 2023171317
Jun 202341914
Jul 2023113514
Aug 202351411
Sep 20234155
Oct 202312158
Nov 20238119
Dec 2023255212
Jan 202418355
Feb 20246228
Mar 202411217
Apr 2024145214
May 202463010
Jun 202435010
Jul 2024137510
Aug 2024159812
Sep 202425516
Oct 202414319
Nov 202415157
Dec 20245336
Jan 202563810
Feb 20256979
Mar 202545510
Apr 202534313
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (11)
Journal of Nuclear Medicine
Vol. 46, Issue 11
November 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
89Zr as a PET Surrogate Radioisotope for Scouting Biodistribution of the Therapeutic Radiometals 90Y and 177Lu in Tumor-Bearing Nude Mice After Coupling to the Internalizing Antibody Cetuximab
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
89Zr as a PET Surrogate Radioisotope for Scouting Biodistribution of the Therapeutic Radiometals 90Y and 177Lu in Tumor-Bearing Nude Mice After Coupling to the Internalizing Antibody Cetuximab
Lars R. Perk, Gerard W.M. Visser, Maria J.W.D. Vosjan, Marijke Stigter-van Walsum, Bernard M. Tijink, C. René Leemans, Guus A.M.S. van Dongen
Journal of Nuclear Medicine Nov 2005, 46 (11) 1898-1906;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
89Zr as a PET Surrogate Radioisotope for Scouting Biodistribution of the Therapeutic Radiometals 90Y and 177Lu in Tumor-Bearing Nude Mice After Coupling to the Internalizing Antibody Cetuximab
Lars R. Perk, Gerard W.M. Visser, Maria J.W.D. Vosjan, Marijke Stigter-van Walsum, Bernard M. Tijink, C. René Leemans, Guus A.M.S. van Dongen
Journal of Nuclear Medicine Nov 2005, 46 (11) 1898-1906;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • 89Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted 227Th-Conjugate Therapy in Mice
  • Detection of incipient pancreatic cancer with novel tumor-specific antibodies in mouse models
  • 89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors
  • PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging
  • Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
  • Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis
  • PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab
  • Three-Dimensional Histologic Validation of High-Resolution SPECT of Antibody Distributions Within Xenografts
  • Molecular Radiotherapy Using Cleavable Radioimmunoconjugates That Target EGFR and {gamma}H2AX
  • Inactivation of HNSCC Cells by 90Y-Labeled Cetuximab Strictly Depends on the Number of Induced DNA Double-Strand Breaks
  • Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody
  • Immuno-PET of Cancer: A Revival of Antibody Imaging
  • ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model
  • Immuno-PET Quantitation of de2-7 Epidermal Growth Factor Receptor Expression in Glioma Using 124I-IMP-R4-Labeled Antibody ch806
  • Preparation, Biological Evaluation, and Pharmacokinetics of the Human Anti-HER1 Monoclonal Antibody Panitumumab Labeled with 86Y for Quantitative PET of Carcinoma
  • Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients
  • Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
  • Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry
  • Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
  • Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications
  • Radioimmunotherapy of Head and Neck Cancer Xenografts Using 131I-Labeled Antibody L19-SIP for Selective Targeting of Tumor Vasculature
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire